Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33899881)
Watch
English
Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
title
Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
author
Elaine Kingwell
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
Marcus W Koch
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
Helen Tremlett
series ordinal
7
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
author name string
B Leung
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
S Isserow
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
J Geddes
series ordinal
5
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
P Rieckmann
series ordinal
6
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
language of work or name
English
0 references
publication date
28 April 2010
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
published in
Neurology
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
volume
74
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
issue
22
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
page(s)
1822-1826
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
cites work
Mitoxantrone treatment of multiple sclerosis: safety considerations
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
28 July 2018
The argument against the use of cyclophosphamide and mitoxantrone in the treatment of multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
28 July 2018
Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
28 July 2018
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
28 July 2018
Treatment of multiple sclerosis with mitoxantrone
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
28 July 2018
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
29 October 2018
Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
29 October 2018
Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
29 October 2018
Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
29 October 2018
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
29 October 2018
Decrease in heart ventricular ejection fraction during multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
29 October 2018
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
29 October 2018
Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
29 October 2018
Cardiotoxicity in patients treated with mitoxantrone: Southwest Oncology Group phase II studies.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882218
retrieved
29 October 2018
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20427751
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20427751
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Liver test abnormalities in multiple sclerosis: Findings from placebo-treated patients
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20427751
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1212/WNL.0B013E3181E0F7E6
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
PMC publication ID
2882218
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
PubMed publication ID
20427751
1 reference
stated in
Europe PubMed Central
PMC publication ID
2882218
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20427751%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
